Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A02462 | 34363921 | J Hepatol | Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis. | 2021 | Details |
| A02463 | 34363644 | Mol Nutr Food Res | Oral Spermidine Targets Brown Fat and Skeletal Muscle to Mitigate Diet-Induced Obesity and Metabolic Disorders. | 2021 | Details |
| A02464 | 34362281 | Scand J Gastroenterol | Negative interaction of fatty liver and hypertension on cardiovascular mortality in non-diabetic men: 34 years of follow-up. | 2021 | Details |
| A02465 | 34362228 | J Clin Med | Association of Body Composition and Sarcopenia with NASH in Obese Patients. | 2021 | Details |
| A02466 | 34362181 | J Clin Med | The APAC Score: A Novel and Highly Performant Serological Tool for Early Diagnosis of Hepatocellular Carcinoma in Patients with Liver Cirrhosis. | 2021 | Details |
| A02467 | 34361619 | Molecules | Antioxidant and Antisteatotic Activities of Fucoidan Fractions from Marine and Terrestrial Sources. | 2021 | Details |
| A02468 | 34360999 | Int J Mol Sci | CYP2E1 in Alcoholic and Non-Alcoholic Liver Injury. Roles of ROS, Reactive Intermediates and Lipid Overload. | 2021 | Details |
| A02469 | 34360923 | Int J Mol Sci | The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target. | 2021 | Details |
| A02470 | 34360904 | Int J Mol Sci | Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA. | 2021 | Details |
| A02471 | 34360773 | Int J Mol Sci | Effect of Microbiome on Non-Alcoholic Fatty Liver Disease and the Role of Probiotics, Prebiotics, and Biogenics. | 2021 | Details |
| A02472 | 34360667 | Int J Mol Sci | Hepatic LKB1 Reduces the Progression of Non-Alcoholic Fatty Liver Disease via Genomic Androgen Receptor Signaling. | 2021 | Details |
| A02473 | 34360607 | Int J Mol Sci | Losartan Prevents Hepatic Steatosis and Macrophage Polarization by Inhibiting HIF-1α in a Murine Model of NAFLD. | 2021 | Details |
| A02474 | 34360538 | Int J Mol Sci | Diabetes Mellitus and Cardiovascular Diseases: Nutraceutical Interventions Related to Caloric Restriction. | 2021 | Details |
| A02475 | 34359991 | Cells | A Narrative Review on the Role of AMPK on De Novo Lipogenesis in Non-Alcoholic Fatty Liver Disease: Evidence from Human Studies. | 2021 | Details |
| A02476 | 34359974 | Cells | Diet-Induced Models of Non-Alcoholic Fatty Liver Disease: Food for Thought on Sugar, Fat, and Cholesterol. | 2021 | Details |
| A02477 | 34359857 | Cells | NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved. | 2021 | Details |
| A02478 | 34359642 | Cancers (Basel) | The Emerging Factors and Treatment Options for NAFLD-Related Hepatocellular Carcinoma. | 2021 | Details |
| A02479 | 34359438 | Foods | Comparison of Egg Yolk and Soybean Phospholipids on Hepatic Fatty Acid Profile and Liver Protection in Rats Fed a High-Fructose Diet. | 2021 | Details |
| A02482 | 34358793 | Curr Opin Pharmacol | Very-low-calorie ketogenic diet: An alternative to a pharmacological approach to improve glycometabolic and gonadal profile in men with obesity. | 2021 | Details |
| A02483 | 34358397 | Liver Int | Association between circulating bile acid alterations and nonalcoholic steatohepatitis independent of obesity and diabetes mellitus. | 2021 | Details |
| A02484 | 34358264 | PLoS One | Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expression. | 2021 | Details |
| A02485 | 34357836 | Curr Med Res Opin | Effect of newer antihyperglycemic drugs on liver steatosis indices in patients with diabetes and obesity. | 2021 | Details |
| A02486 | 34357000 | Medicina (Kaunas) | Non-Alcoholic Fatty Liver Disease in Children. | 2021 | Details |
| A02487 | 34356308 | Antioxidants (Basel) | Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism. | 2021 | Details |
| A02488 | 34356275 | Healthcare (Basel) | Prediction of Cardiovascular Risk Using Nonalcoholic Fatty Liver Disease Scoring Systems. | 2021 | Details |
| A02489 | 34355342 | Endocrine | Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus. | 2021 | Details |
| A02490 | 34355282 | Metabolomics | Short-term changes in the serum metabolome after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. | 2021 | Details |
| A02491 | 34355155 | JHEP Rep | A dynamic association between myosteatosis and liver stiffness: Results from a prospective interventional study in obese patients. | 2021 | Details |
| A02492 | 34354193 | Sci Rep | Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease. | 2021 | Details |
| A02493 | 34353693 | J Ayurveda Integr Med | Intervention by picroside II on FFAs induced lipid accumulation and lipotoxicity in HepG2 cells. | 2021 | Details |
| A02494 | 34353365 | Clin Epigenetics | Differential DNA methylation and changing cell-type proportions as fibrotic stage progresses in NAFLD. | 2021 | Details |
| A02495 | 34352984 | Diabetes Metab J | 2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association. | 2021 | Details |
| A02496 | 34352720 | Diabetes Metab Syndr | Meta-analysis of trials in non-alcoholic fatty liver disease with therapeutic interventions for metabolic syndrome. | 2021 | Details |
| A02497 | 34352133 | J Viral Hepat | COVID-19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later. | 2021 | Details |
| A02498 | 34351342 | Food Funct | CD36 and DGAT2 facilitate the lipid-lowering effect of chitooligosaccharides via fatty acid intake and triglyceride synthesis signaling. | 2021 | Details |
| A02499 | 34351306 | Horm Res Paediatr | Nonalcoholic Fatty Liver Disease in Children with Obesity: Narrative Review and Research Gaps. | 2021 | Details |
| A02500 | 34350519 | Dig Dis Sci | Endoscopic Ultrasound Finding of Diffuse Echogenicity in the Pancreas, Is It Relevant? | 2021 | Details |
| A02501 | 34350196 | Front Med (Lausanne) | Prevalence and Incidence of Non-alcohol Fatty Liver Disease in Chronic Hepatitis B Population in Southeast China: A Community-Based Study. | 2021 | Details |
| A02502 | 34349877 | Nutr Res Pract | Efficacy of nobiletin in improving hypercholesterolemia and nonalcoholic fatty liver disease in high-cholesterol diet-fed mice. | 2021 | Details |
| A02503 | 34349537 | Diabetes Metab Syndr Obes | Estimation of the Prevalence of Nonalcoholic Fatty Liver Disease in an Adult Population in Northern China Using the Data Mining Approach. | 2021 | Details |
| A02504 | 34349535 | Diabetes Metab Syndr Obes | MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis. | 2021 | Details |
| A02505 | 34348882 | Dig Liver Dis | Genetic predisposition, lifestyle risk, and obesity associate with the progression of nonalcoholic fatty liver disease. | 2021 | Details |
| A02506 | 34348707 | J Nanobiotechnology | Improving the ameliorative effects of berberine and curcumin combination via dextran-coated bilosomes on non-alcohol fatty liver disease in mice. | 2021 | Details |
| A02507 | 34348281 | Dig Dis | ALT Levels in Treatment-Naive, Chronic Hepatitis B Patients with Concurrent Fatty Liver Disease: A US Nationwide Study. | 2021 | Details |
| A02508 | 34347796 | PLoS One | Perchlorate exposure does not induce obesity or non-alcoholic fatty liver disease in zebrafish. | 2021 | Details |
| A02509 | 34347479 | J Agric Food Chem | Hepatic Lipidomics Analysis Reveals the Ameliorative Effects of Highland Barley β-Glucan on Western Diet-Induced Nonalcoholic Fatty Liver Disease Mice. | 2021 | Details |
| A02510 | 34346799 | Expert Rev Mol Diagn | Nonalcoholic fatty liver disease: use of diagnostic biomarkers and modalities in clinical practice. | 2021 | Details |
| A02511 | 34346124 | Cell Prolif | Curcumol inhibits ferritinophagy to restrain hepatocyte senescence through YAP/NCOA4 in non-alcoholic fatty liver disease. | 2021 | Details |
| A02512 | 34346007 | J Gen Intern Med | Does Point-of-Care Ultrasound Change the Needle Insertion Location During Routine Bedside Paracentesis? | 2021 | Details |
| A02513 | 34345229 | EXCLI J | The association between epicardial adipose tissue and non-alcoholic fatty liver disease: A systematic review of existing human studies. | 2021 | Details |
| A02514 | 34344394 | Chin Med | Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives. | 2021 | Details |
| A02515 | 34344333 | BMC Endocr Disord | Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease. | 2021 | Details |
| A02516 | 34344058 | Diabetes Metab Res Rev | Serum creatinine levels and risk of nonalcohol fatty liver disease in a middle-aged and older Chinese population: A cross-sectional analysis. | 2021 | Details |
| A02517 | 34343577 | Metabolism | Intestine-liver crosstalk in Type 2 Diabetes and non-alcoholic fatty liver disease. | 2021 | Details |
| A02518 | 34343274 | Endocrinology | SGLT2 Inhibition for Cardiovascular Diseases, Chronic Kidney Disease, and NAFLD. | 2021 | Details |
| A02519 | 34342335 | Ann Acad Med Singap | New-onset cardiovascular risk factors following liver transplantation: A cohort analysis in Singapore. | 2021 | Details |
| A02520 | 34342231 | J Agric Food Chem | Phloridzin Ameliorates Lipid Deposition in High-Fat-Diet-Fed Mice with Nonalcoholic Fatty Liver Disease via Inhibiting the mTORC1/SREBP-1c Pathway. | 2021 | Details |
| A02521 | 34342168 | Physiol Rep | Hormonal regulation of glycine decarboxylase and its relationship to oxidative stress. | 2021 | Details |
| A02522 | 34342164 | Physiol Rep | The effect of endurance training on non-alcoholic fatty liver disease in mice. | 2021 | Details |
| A02523 | 34341928 | Environ Sci Pollut Res Int | Metronidazole enhances steatosis-related early-stage hepatocarcinogenesis in high fat diet-fed rats through DNA double-strand breaks and modulation of autophagy. | 2021 | Details |
| A02524 | 34341404 | Sci Rep | Sarcopenia modifies the associations of nonalcoholic fatty liver disease with all-cause and cardiovascular mortality among older adults. | 2021 | Details |
| A02525 | 34341368 | Sci Rep | Effect of skin-capsular distance on controlled attenuation parameter for diagnosing liver steatosis in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A02526 | 34341018 | BMJ Open Gastroenterol | Plasminogen activator inhibitor is significantly elevated in liver transplant recipients with decompensated NASH cirrhosis. | 2021 | Details |
| A02527 | 34340957 | Endocrinol Diabetes Nutr (Engl Ed) | Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity. | 2021 | Details |
| A02528 | 34340181 | Environ Pollut | An adverse outcome pathway based in vitro characterization of novel flame retardants-induced hepatic steatosis. | 2021 | Details |
| A02529 | 34339945 | Phytomedicine | Investigating the medicinal potential, material basis and mechanism of Polygoni Orientalis Fructus based on multi-technology integrated network pharmacology. | 2021 | Details |
| A02530 | 34339944 | Phytomedicine | Network pharmacology-based identification of significant pathway for protection of Yinhuang granule in a mice model of metabolic-associated fatty liver disease. | 2021 | Details |
| A02531 | 34339914 | Biomed Pharmacother | Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease. | 2021 | Details |
| A02532 | 34339764 | J Hepatol | Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention. | 2021 | Details |
| A02533 | 34338703 | Food Funct | Co-supplementation of camelina oil and a prebiotic is more effective for in improving cardiometabolic risk factors and mental health in patients with NAFLD: a randomized clinical trial. | 2021 | Details |
| A02534 | 34337887 | J Cachexia Sarcopenia Muscle | Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease. | 2021 | Details |
| A02535 | 34337376 | Metabol Open | The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease. | 2021 | Details |
| A02536 | 34336516 | Cureus | Perception of Non-Alcoholic Fatty Liver Disease: Real-Life Experience From Pakistan. | 2021 | Details |
| A02537 | 34336366 | Liver Res | Adoptive transfer of Pfkfb3-disrupted hematopoietic cells to wild-type mice exacerbates diet-induced hepatic steatosis and inflammation. | 2020 | Details |
| A02538 | 34335826 | Evid Based Complement Alternat Med | Scolymus hispanicus (Golden Thistle) Ameliorates Hepatic Steatosis and Metabolic Syndrome by Reducing Lipid Accumulation, Oxidative Stress, and Inflammation in Rats under Hyperfatty Diet. | 2021 | Details |
| A02539 | 34335686 | Front Genet | The Co-occurrence of Chronic Hepatitis B and Fibrosis Is Associated With a Decrease in Hepatic Global DNA Methylation Levels in Patients With Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A02540 | 34335574 | Front Immunol | Inhibition of Extracellular Cathepsin D Reduces Hepatic Lipid Accumulation and Leads to Mild Changes in Inflammationin NASH Mice. | 2021 | Details |
| A02541 | 34335310 | Front Physiol | Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease. | 2021 | Details |
| A02542 | 34334708 | Eur J Gastroenterol Hepatol | Predictive value of cytokeratin-18 fragment levels for diagnosing steatohepatitis in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A02543 | 34333790 | Hepatology | A Machine Learning Approach to Liver Histological Evaluation Predicts Clinically Significant Portal Hypertension in NASH Cirrhosis. | 2021 | Details |
| A02544 | 34333285 | Biomed Pharmacother | Protective effects of p-coumaric acid against high-fat diet-induced metabolic dysregulation in mice. | 2021 | Details |
| A02545 | 34333032 | Fitoterapia | Four new dammarane triterpenoid glycosides from the leaves of Cyclocarya paliurus and their SIRT1 activation activities. | 2021 | Details |
| A02546 | 34332979 | Life Sci | Dimethyl fumarate reduces oxidative stress, inflammation and fat deposition by modulation of Nrf2, SREBP-1c and NF-κB signaling in HFD fed mice. | 2021 | Details |
| A02547 | 34332133 | Clin Res Hepatol Gastroenterol | Non-invasive diagnosis and follow-up of non-alcoholic fatty liver disease. | 2021 | Details |
| A02550 | 34331779 | Hepatology | Hepatic Mitochondrial SAB Deletion or Knockdown Alleviates Diet-Induced Metabolic Syndrome, Steatohepatitis, and Hepatic Fibrosis. | 2021 | Details |
| A02551 | 34331020 | Pediatr Res | Angiopoietin-2 levels correlates with disease activity in children with nonalcoholic fatty liver disease. | 2021 | Details |
| A02552 | 34330514 | Clin Nutr ESPEN | Contribution of gut microbiota to nonalcoholic fatty liver disease: Pathways of mechanisms. | 2021 | Details |
| A02553 | 34330512 | Clin Nutr ESPEN | Triglyceride glucose (TyG) index and the progression of liver fibrosis: A cross-sectional study. | 2021 | Details |
| A02554 | 34330456 | Clin Nutr ESPEN | Effect of omega-3 supplementation on fatty liver and visceral adiposity indices in diabetic patients with non-alcoholic fatty liver disease: A randomized controlled trial. | 2021 | Details |
| A02555 | 34330452 | Clin Nutr ESPEN | Polyphenols in the prevention and treatment of non-alcoholic fatty liver disease: An update of preclinical and clinical studies. | 2021 | Details |
| A02556 | 34329714 | J Ethnopharmacol | Pharmacokinetic herb-disease-drug interactions: Effect of ginkgo biloba extract on the pharmacokinetics of pitavastatin, a substrate of Oatp1b2, in rats with non-alcoholic fatty liver disease. | 2021 | Details |
| A02557 | 34328687 | Liver Int | Zonation in NASH - A key paradigm for understanding pathophysiology and clinical outcomes. | 2021 | Details |
| A02558 | 34328446 | Am J Gastroenterol | The Changing Epidemiology of Liver Disease Among US Children and Adolescents From 1999 to 2016. | 2021 | Details |
| A02560 | 34328248 | Liver Int | Diet and exercise in NAFLD/NASH: Beyond the obvious. | 2021 | Details |
| A02561 | 34328120 | Biomed Pharmacother | Molecular mechanism of DLBS3733, a bioactive fraction of Lagerstroemia speciosa (L.) Pers., on ameliorating hepatic lipid accumulation in HepG2 cells. | 2021 | Details |
| A02562 | 34328087 | Biomed Pharmacother | Supplementation of cumin seed powder prevents oxidative stress, hyperlipidemia and non-alcoholic fatty liver in high fat diet fed rats. | 2021 | Details |
| A02563 | 34327759 | Phytother Res | Recent developments in the regulation of cholesterol transport by natural molecules. | 2021 | Details |
| A02564 | 34327606 | Endocrine | Chronic angiotensin receptor activation promotes hepatic triacylglycerol accumulation during an acute glucose challenge in obese-insulin-resistant OLETF rats. | 2021 | Details |
| A02565 | 34327498 | Am J Prev Cardiol | Health disparities in cardiometabolic risk among Black and Hispanic youth in the United States. | 2021 | Details |
| A02566 | 34327473 | Am J Prev Cardiol | The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: A longitudinal study. | 2020 | Details |